Patient info Open main menu

Pioglitazone Torrent 30 mg tablets – patient leaflet, side effects, dosage

Last updated: · Text from the MHRA, as of · About this document

Medicine status: Prescription only (POM) Details

Medicine strength:
30 mg
Contains active substance:

Patient leaflet - Pioglitazone Torrent 30 mg tablets

1. What Pioglitazone is and what it is used for

heart failure such as unusual shortness of breath or rapid increase in weight or localized swelling (oedema). If you take Pioglitazone with other medicines for diabetes, it is more likely that your blood sugar could fall below the normal level (hypoglycaemia).

You may also experience a reduction in blood count (anaemia). Broken bones

A higher number of bone fractures was seen in patients, particularly women taking pioglitazone. Your doctor will take this into account when treating your diabetes.

Children and adolescents

Use in children and adolescents under 18 years is not recommended.

Other medicines and Pioglitazone

Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines, including medicines obtained without a prescription.

You can usually continue to take other medicines whilst you are being treated with Pioglitazone. However, certain medicines are especially likely to affect the amount of sugar in your blood:

  • Gemfibrozil (used to lower cholesterol)
  • Rifampicin (used to treat tuberculosis and other infections).

Tell your doctor or pharmacist if you are taking any of these. Your blood sugar will be checked, and your dose of Pioglitazone may need to be changed.

Pioglitazone contains pioglitazone. It is an anti-diabetic medicine used to treat type 2 (non-insulin dependent) diabetes mellitus in adults, when metformin is not suitable or has failed to work adequately. This is the diabetes that usually develops in adulthood.

Pioglitazone tablets helps control the level of sugar in your blood when you have type 2 diabetes by helping your body make better use of the insulin it produces. Your doctor will check whether Pioglitazone is working 3 to 6 months after you start taking it.

Pioglitazone tablets with food, drink and alcohol:

You may take your tablets with or without food. You should swallow the tablets with a glass of water.

Pregnancy, breastfeeding and fertility:

Tell your doctor if

  • you are, you think you might be or are planning to become pregnant.
  • you are breastfeeding or if you are planning to breast-feed your baby.

Your doctor will advise you to discontinue this medicine.

Pioglitazone tablets may be used on its own in patients who are unable to take metformin, and where treatment with diet and exercise has failed to control blood sugar or may be added to other therapies (such as metformin, sulphonylurea or insulin) which have failed to provide sufficient control in blood sugar.

2. What you need to know before you take Pioglitazone

Do not take Pioglitazone tablets:

  • If you are allergic to pioglitazone or any of the other ingredients of this medicine (listed in section 6).
  • If you have heart failure or have had heart failure in the past.
  • If you have liver disease.
  • If you have had diabetic ketoacidosis (a complication of diabetes causing rapid weight loss, nausea or vomiting).
  • If you have or have ever had bladder cancer.
  • If you have blood in your urine that your doctor has not checked.

Warnings and precautions

Talk to your doctor or pharmacist before taking Pioglitazone (also see Section 4):

  • If you retain water (fluid retention) or have heart failure problems, in particular if you are over 75 years old. If you take anti-inflammatory medicines which can also cause fluid retention and swelling, you must also tell your doctor.
  • If you have a special type of diabetic eye disease called macular oedema (swelling of the back of the eye).
  • If you have cysts on your ovaries (polycystic ovary syndrome). There may be an increased possibility of becoming pregnant because you may ovulate again when you take Pioglitazone. If this applies to you, use appropriate contraception to avoid possibility of an unplanned pregnancy.
  • If you have a problem with your liver or heart. Before you start taking Pioglitazone you will have a blood sample taken to check your liver function. This check may be repeated at intervals. Some patients with long-standing type 2 diabetes mellitus and heart disease or previous stroke who were treated with Pioglitazone and insulin experienced the development of heart failure. Inform your doctor as soon as possible if you experience signs of

    Driving and using machines:

    Pioglitazone will not affect your ability to drive or use machines but take care if you experience abnormal vision.

    Pioglitazone contains lactose monohydrate

    This medicinal product contains lactose monohydrate. If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking Pioglitazone tablets.

3. How to take Pioglitazone

Always take this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure.

The usual starting dose is one tablet of 15 mg or of 30 mg of pioglitazone to be taken once daily. Your doctor may increase the dose to a maximum of 45 mg once a day. Your doctor will tell you the dose to take.

For 30 mg - The tablet can be divided into equal halves. For 45 mg - The scoreline is not intended for breaking the tablet

If you have the impression that the effect of Pioglitazone tablets is too weak, talk to your doctor.

When Pioglitazone tablets are taken in combination with other medicines used to treat diabetes (such as insulin, chlorpropamide, glibenclamide, gliclazide, tolbutamide) your doctor will tell you whether you need to take a smaller dose of your medicines.

Your doctor will ask you to have blood tests periodically during treatment with Pioglitazone. This is to check that your liver is working normally.

If you are following a diabetic diet, you should continue with this while you are taking Pioglitazone tablets.

Your weight should be checked at regular intervals; if your weight increases, inform your doctor.

If you take more Pioglitazone tablets than you should:

If you accidentally take too many tablets, or if someone else or a child takes your medicine, talk to a doctor or pharmacist immediately. Your blood sugar could fall below the normal

LOCATION : IndradCOUNTRY : UK
SIZE : 175 x 310 mm_Front/Back SideCODE : 8108978-7803DATE : 25-03-2026
REMARK : Folding Length 35 mm
SUBSTRATE :
ActivitiesDepartmentNameSignatureDate

level and can be increased by taking sugar. It is recommended that you carry some sugar lumps, sweets, biscuits or sugar fruit juice.

If you forget to take Pioglitazone tablets:

Take Pioglitazone tablets daily as prescribed. However if you miss a dose, just carry on with the next dose as normal. Do not take a double dose to make up for a forgotten tablet.

If you stop taking Pioglitazone tablets:

Pioglitazone tablets should be used every day to work properly. If you stop taking Pioglitazone your blood sugar may go up. Talk to your doctor before stopping this treatment. If you have any further questions on the use of this medicine, ask your doctor or pharmacist or nurse.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

In particular, patients have experienced the following serious side effects:

Heart failure has been experienced commonly (may affect up to 1 in 10 people) in patients taking pioglitazone in combination with insulin. Symptoms are unusual shortness of breath or rapid increase in weight or localised swelling (oedema). If you experience any of these, especially if you are over the age of 65, seek medical advice straight away. Bladder cancer has been experienced uncommonly (may affect up to 1 in 100 people) in patients taking pioglitazone. Signs and symptoms include blood in your urine, pain when urinating or a sudden need to urinate. If you experience any of these, talk to your doctor as soon as possible.

Localised swelling (oedema) has also been experienced very commonly (may affect more than 1 in 10 people) in patients taking pioglitazone in combination with insulin. If you experience this side effect, talk to your doctor as soon as possible.

Broken bones have been reported commonly (may affect up to 1 in 10 people) in female patients taking pioglitazone and have also been reported in male patients (frequency cannot be estimated from the available data) taking pioglitazone. If you experience this side effect, talk to your doctor as soon as possible.

Blurred vision due to swelling (or fluid) at the back of the eye (frequency cannot be estimated from available data) has also been reported in patients taking pioglitazone. If you experience this symptom for the first time, talk to your doctor as soon as possible. Also, if you already have blurred vision and the symptom gets worse, talk to your doctor as soon as possible.

  • joint pain
  • impotence
  • back pain
  • shortness of breath
  • small reduction in red blood cell count
  • flatulence

Uncommon (may affect up to 1 in 100 people)

  • sugar in urine, proteins in urine
  • increase in enzymes
  • spinning sensation (vertigo)
  • sweating
  • tiredness
  • increased appetite

Reporting of side effects

If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the national reporting system Yellow Card Scheme; Website: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects you can help provide more information on the safety of this medicine.

5. How to store Pioglitazone

Keep this medicine out of the sight and reach of children. Do not use this medicine after the expiry date which is stated on the carton and the blister pack after the word “EXP”. The expiry data refers to the last day of that month. Store below 25 °C.

Do not throw away any medicines of via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.

6. Contents of the pack and other information

What Pioglitazone contains

The active substance is pioglitazone. Each tablet contains 15 mg, 30 mg or 45 mg of pioglitazone (as hydrochloride). The other ingredients are lactose monohydrate, carmellose calcium, hydroxypropyl cellulose and magnesium stearate.

What Pioglitazone looks like and contents of the pack

Pioglitazone 15 mg: white to off-white, round, flat faced beveled edge uncoated tablets debossed with ‘15’ on one side and plain on the other side.

Pioglitazone 30 mg: white to off-white, round, flat faced beveled edge uncoated tablets with breakline on both sides. Pioglitazone 45 mg: white to off-white, round, flat faced beveled edge uncoated tablets debossed with ‘T’ shape breakline on both sides.

Allergic reactions have been reported (frequency cannot be estimated from the available data) in patients taking pioglitazone. If you have a serious allergic reaction, including hives and swelling of the face, lips, tongue, or throat that may cause difficulty in breathing or swallowing stop taking this medicine and talk to your doctor as soon as possible. The other side effects that have been experienced by some patients taking Pioglitazone are:

Common (may affect up to 1 in 10 people)

  • respiratory infection
  • abnormal vision
  • weight gain
  • numbness

    Triplex (PVC/PE/PVdC)/Al blisters or OPA/Al/PVC/Al blisters

    Packs of 28, 30, 50, 98, 120 and 200 tablets

    Not all pack sizes may be marketed.

    Marketing Authorisation Holder and Manufacturer

    Torrent Pharma (UK) Ltd.

    3rd Floor, Nexus Building,

    4 Gatwick Road, Crawley,

    West Sussex, RH10 9BG,

    United Kingdom

    This leaflet was last revised in 3/2026

Uncommon (may affect up to 1 in 100 people)

  • inflammation of the sinuses (sinusitis)
  • difficulty sleeping (insomnia)

Not known (frequency cannot be estimated from the available data)

  • increase in liver enzymes.
  • allergic reactions

The other side effects that have been experienced by some patients when Pioglitazone is taken with other antidiabetic medicines are:

Very common (may affect more than 1 in 10 people)

  • decreased blood sugar (hypoglycaemia) Common (may affect up to 1 in 10 people)
  • headache
  • dizziness 8108978-7803

About this document

Source: MHRA - Medicines and Healthcare products Regulatory Agency (products.mhra.gov.uk) · Marketing authorisation: PL 36687/0112

Last revision stated in the text: March 2026 · MHRA data as of 13 October 2026

Found a mistake? Tell us on the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Facts about Pioglitazone Torrent 30 mg tablets

Prescription needed? Yes, prescription-only medicine (POM)
Active substance Pioglitazone
Strength 30 mg
Pharmaceutical form Oral tablet
White to off-white, round, flat faced beveled edge uncoated tablets with breakline on both sides.
Diameter: 7.00 ± 0.25 mm (6.75 mm to 7.25 mm). The tablet can be divided into equal halves.
How is it taken Oral
Excipients Lactose monohydrate, Carmellose calcium, Hydroxypropylcellulose, Magnesium stearate
Pack sizes 28 tablet
Is it available? Listed as available (NHS Dictionary of Medicines and Devices – not a record of current supplies)
Shelf life 3 years
Storage Store below 25 °C.
Drug group (ATC) Drugs used in diabetes, blood glucose lowering drugs, excl. insulins
  1. A Alimentary tract and metabolism drugs
    1. A10 Drugs used in diabetes
      1. A10B Blood glucose lowering drugs, excl. insulins
        1. A10BG Thiazolidinediones, blood glucose lowering drugs
          1. A10BG03 pioglitazone
Marketing authorisation PL 36687/0112 (first authorised 6 October 2019)
Marketing authorisation holder Torrent Pharma (UK) Ltd.
Codes GTIN 5060623370534 · BNF 06010203

Sources: the MHRA product information (products.mhra.gov.uk) and the NHS Dictionary of Medicines and Devices (dm+d), release 10.2.0 of 19 October 2026, NHS Business Services Authority. Contains public sector information licensed under the Open Government Licence v3.0.